Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Latest Non-steroidal anti-inflammatory drugs Stories

2013-02-19 08:31:38

NASHVILLE, Tenn., Feb. 19, 2013 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) today announced top-line results from two registry studies evaluating the safety and efficacy of Caldolor® (ibuprofen) Injection administered over a shortened infusion time in treating pain and fever in adult patients. The studies involved 450 patients receiving Caldolor at 35 leading medical centers throughout the United States. The first of two registry studies was a phase IV multi-center,...

2013-02-14 12:25:43

WILMINGTON, Del., Feb. 14, 2013 /PRNewswire/ -- SPI Pharma, Inc. (Wilmington, DE), a global leader in providing pharmaceutical ingredients and technologies for patient-friendly dosage forms, announces the launch of Actimask® Ibuprofen 92S, a taste-masked Ibuprofen. It joins Actimask Acetaminophen 92M in SPI's line of taste-masked actives specifically designed for making patient-friendly orally dispersible dosage forms economically in conventional equipment. Actimask Ibuprofen 92S is...

2013-02-13 11:28:50

Diclofenac most commonly used non-steroidal anti-inflammatory drug in 15 countries, listed on 74 national drug lists, despite cardiovascular risks A study in this week's PLOS Medicine finds that the painkiller diclofenac (a non-steroidal anti-inflammatory drug (NSAID) in the same class as aspirin) is the most commonly used NSAID in the 15 countries studied and is included in the essential medicines lists of 74 low-, middle- and high-income countries, despite its known tendency to cause...

2013-02-11 08:25:55

CAMBRIDGE, Mass., Feb. 11, 2013 /PRNewswire/ -- Catabasis Pharmaceuticals, Inc., today announced that a three-part series of Phase 1 studies showed that CAT-1004, a SMART Linker conjugate of docosahexaenoic acid (DHA) and salicylate created using the company's proprietary technology, was safe and well tolerated. Data also show that the conjugated compound was absorbed following oral administration and metabolized to its active components intracellularly, providing proof of concept for the...

2013-02-04 08:25:00

FRANKFURT, Germany and LONDON, February 4, 2013 /PRNewswire/ -- The Federal Association of German Pharmacists (BVDA) today presented its "Innovation Award 2013" to FLEXISEQ(R), an innovative new treatment for pain and stiffness associated with osteoarthritis (OA). The BVDA president, and pharmacist Thomas Hieble, explained; "The jury awarded the prize to FLEXISEQ(R) in recognition of the application of its innovative Sequessome Technology(R) to deliver symptom relief to...

2013-01-29 12:27:08

NASHVILLE, Tenn., Jan. 29, 2013 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) today announced it has entered into an exclusive agreement with Indonesia's PT. SOHO Industri Pharmasi (a SOHO Group company) for the registration and commercialization of Caldolor® (ibuprofen) Injection, which is used to treat pain and fever in the hospital setting. Under the terms of the agreement, SOHO receives an exclusive license to Caldolor for the Indonesian market. SOHO will be...

2013-01-29 08:29:54

MISSISSAUGA, ON, Jan. 29, 2013 /PRNewswire/ - Nuvo Research Inc. (Nuvo) (TSX: NRI) announced today that it has entered into a settlement agreement with Apotex Inc. and Apotex Corp. (together Apotex) respecting patent infringement litigation brought by Nuvo and Nuvo's U.S. licensing partner, Mallinckrodt Inc. (Mallinckrodt), in response to Apotex's filing of an abbreviated new drug application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market a generic...

2013-01-22 08:31:17

MADISON, Tenn., Jan. 22, 2013 /PRNewswire/ -- All across America, independent pharmacies and healthcare providers are on the frontlines of pain relief. Consumers and patients rely on the advice and expertise they receive from professionals on the ground locally to control pain and inflammation related to arthritis, muscle strain, joint and back injury, fibromyalgia, plantar fasciitis, headaches, menstrual cramps and more. Given the following facts, retailers and health practitioners bear a...

Aspirin Use Linked To Elderly Vision Loss
2013-01-22 04:57:38

Connie K. Ho for redOrbit.com — Your Universe Online Scientists from the University of Sydney, Australia recently found that there is a relationship between regular aspirin use and elevated risk of age-related macular degeneration (AMD). In particular, aspirin is a commonly used medication that has been used to help prevent cardiovascular disease, including heart attacks and ischemic stroke. Regular aspirin use has been stated as use at least once or more during the week. AMD, on the...

2013-01-09 12:26:44

Absolute risk still low, but doctors and patients should be vigilant Patients who take a triple combination of blood pressure drugs and common painkillers are at an increased risk of serious kidney problems, especially at the start of treatment, finds a study published on bmj.com today. Although the absolute risk for individuals is low, it is still something doctors and patients should be aware of, say the researchers. Acute kidney injury (also known as kidney failure) is a major...